Factor XIa Inhibitors Show Promise in Stroke Prevention
Featured

Factor XIa Inhibitors Show Promise in Stroke Prevention

Clinic Moves

FDA Approves New Treatments for Brain Disorders
Clinic Moves
August 22, 2026

FDA Approves New Treatments for Brain Disorders

FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam...

Website Users Unable to Access Content After Blocking
Clinic Moves
August 21, 2026

Website Users Unable to Access Content After Blocking

New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson...

Bird flu fears prompt calls for aid
Clinic Moves
August 10, 2026

Bird flu fears prompt calls for aid

Australia faces severe ecological and economic threats from bird flu, with 175 confirmed cases across...

Drug Approvals

Read our latest Drug Approvals articles.

UN health talks amid disease fears and leadership race
Drug Approvals August 17, 2026

UN health talks amid disease fears and leadership race

Republican lawmakers vote to hold Fauci in contempt of Congress over COVID-19 pandemic handling disputes,...

Law on assisted dying must be changed
Drug Approvals August 16, 2026

Law on assisted dying must be changed

Greens Senator introduces bill to change assisted dying law to allow telehealth access, improving access...

Outbreak Watch

Trial Briefs

All Posts

Factor XIa Inhibitors Show Promise in Stroke Prevention
Drug Approvals

Factor XIa Inhibitors Show Promise in Stroke Prevention

Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering better protection than aspirin or...

FDA Approves New Treatments for Brain Disorders
Clinic Moves

FDA Approves New Treatments for Brain Disorders

FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam drug application.

Website Users Unable to Access Content After Blocking
Clinic Moves

Website Users Unable to Access Content After Blocking

New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson patients. Read the latest analysis...

Policymaking toolkit exposes privilege disparities
Outbreak Watch

Policymaking toolkit exposes privilege disparities

Researchers develop toolkit to address policymaking privilege disparities and inequities in public policy decisions.

Architects of the hunt design deadly strategies
Trial Briefs

Architects of the hunt design deadly strategies

Architects of the hunt design deadly strategies in media regulation. Sign the open letter calling for a public inquiry into...

UN health talks amid disease fears and leadership race
Drug Approvals

UN health talks amid disease fears and leadership race

Republican lawmakers vote to hold Fauci in contempt of Congress over COVID-19 pandemic handling disputes, escalating political tensions.

Law on assisted dying must be changed
Drug Approvals

Law on assisted dying must be changed

Greens Senator introduces bill to change assisted dying law to allow telehealth access, improving access for medically supported voluntary assisted...

Australia cannot afford business as usual amid Northern Hemisphere fires
Vaccine News

Australia cannot afford business as usual amid Northern Hemisphere fires

Australia cannot afford business as usual amid Northern Hemisphere fires, as global climate crises intensify. Learn how these events affect...

Trump’s health policies spark nationwide backlash
Drug Approvals

Trump’s health policies spark nationwide backlash

Trump’s vaccine policy sparks nationwide debate over parental choice and public health risks amid reduced childhood vaccine recommendations.

Patients left at risk by poor communication standards
Trial Briefs

Patients left at risk by poor communication standards

Australia’s new health safety standards may overlook critical communication risks for deaf patients, leaving them at risk. Share your feedback...

Show More →